Location: Home
  • search
  • go
  • Relate News
  • 7/28/2020Lynk Pharma enters exclusive licensing Deals with Kobe University and ...
  • 7/28/2020Chi-Med's NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Pr...
  • 7/28/2020Pfizer to Promote CanSino Biologics' Menhycia Meningitis Vaccine Candi...
  • 7/28/2020Chi-Med and Lilly Amend/Expand Agreement to Co-promote Elunate in Chin...
  • 7/28/2020China Inaugurates National Respiratory Medicine Center in Beijing
  • 7/28/2020China: Looking Back at 2019's Main IP Developments and Looking Forward...
  • 7/25/2020BeiGene Announces Acceptance of NDA for Pamiparib in Ovarian Cancer in...
  • 7/25/2020NHC Issues the Action Plan for Healthcare Sector Ethics Building Initi...
  • 7/25/2020NHSA Solicits Feedbacks on Draft Guidance Opinions for Establishing Dr...
  • 7/25/2020Recent Executive Moves
  • 7/24/2020CDE Solicits Comments on the Draft Technical Guidelines for Pharmacy S...
  • 7/24/2020CDE Issues the Guidelines for Non-inferiority Design of Drug Clinical ...
  • 7/24/2020Chi-Med Initiates a Phase I Trial of IDH1/2 Dual Inhibitor for Hematol...
  • 7/24/2020Tigermed to Raise At Least $1B in Hong Kong IPO
  • 7/23/2020State Council Issues Notice on Core Tasks to Deepen Healthcare Reform ...
  • 7/23/2020Hansoh and EQRx Enter Strategic Deal for Almonertinib
  • 7/23/2020NHC Issues Notice to Boost Surveillance of Pediatric Antibiotic Clinic...
  • 7/23/2020NHC Issues Official Notice for Sustained Clinical Application Regulati...
  • 7/23/2020Sunshine Guojian Pharma Launches IPO on Shanghai STAR Market
  • 7/22/2020SinoMab Entered into Strategic Deal with D2M for Novel Drug Target Ide...
  • 7/22/2020143 Listed Chinese MedPharm Cos Report H1 Performance
  • 7/22/2020JW Therapeutics Buys Hong Kong Anti-cancer Drug Maker Syracuse Biophar...
  • 7/22/2020China Oncology Drugs Market - Growth Opportunities Created by Covid-19...
  • 7/22/2020NMPA Announces OTC Switch of Two Prescription Drugs
  • 7/22/2020China Prepares for the Third Batch of National Volume-based Procuremen...
  • 7/21/2020NMPA Issues Announcement for Applicability of ICH E2C(R2)
  • 7/21/2020Shionogi Finalizes JV with Ping An Insurance in Shanghai
  • 7/20/2020BeiGene and Assembly Bio Ink $540M China HBV Deal
  • 7/20/2020NMPA Accepts Deciphera's NDA Submission of Ripretinib for Advanced GI ...
  • 7/20/2020CDE Issues the Clinical Research Guidelines for Rituximab Biosimilar
  • Page:256/802 Total number of articles:24058: [First][<<] [254] [255] [256] [257] [258] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group